» Articles » PMID: 38862714

Nutrient-delivery and Metabolism Reactivation Therapy for Melanoma

Overview
Journal Nat Nanotechnol
Specialty Biotechnology
Date 2024 Jun 11
PMID 38862714
Authors
Affiliations
Soon will be listed here.
Abstract

To fulfil the demands of rapid proliferation, tumour cells undergo significant metabolic alterations. Suppression of hyperactivated metabolism has been proven to counteract tumour growth. However, whether the reactivation of downregulated metabolic pathways has therapeutic effects remains unexplored. Here we report a nutrient-based metabolic reactivation strategy for effective melanoma treatment. L-Tyrosine-oleylamine nanomicelles (MTyr-OANPs) were constructed for targeted supplementation of tyrosine to reactivate melanogenesis in melanoma cells. We found that reactivation of melanogenesis using MTyr-OANPs significantly impeded the proliferation of melanoma cells, primarily through the inhibition of glycolysis. Furthermore, leveraging melanin as a natural photothermal reagent for photothermal therapy, we demonstrated the complete eradication of tumours in B16F10 melanoma-bearing mice through treatment with MTyr-OANPs and photothermal therapy. Our strategy for metabolism activation-based tumour treatment suggests specific nutrients as potent activators of metabolic pathways.

Citing Articles

NIR-II Fluorescent Thermophoretic Nanomotors for Superficial Tumor Photothermal Therapy.

Jiang J, Hu J, Li M, Luo M, Dong B, Sitti M Adv Mater. 2025; 37(10):e2417440.

PMID: 39895191 PMC: 11899490. DOI: 10.1002/adma.202417440.


Nanotechnology-based tumor metabolic reprogramming: Insights into nutrient-delivery and metabolism reactivation therapy.

Hu X, Ling D Acta Pharm Sin B. 2024; 14(10):4619-4621.

PMID: 39525576 PMC: 11544171. DOI: 10.1016/j.apsb.2024.07.015.


Fluoride dielectrics for 2D transistors.

Grasser T, Waltl M, Knobloch T Nat Nanotechnol. 2024; 19(7):880-881.

PMID: 38977860 DOI: 10.1038/s41565-024-01710-5.


Artificial intelligence assists the synthesis of all-natural plastic substitutes.

Liu Z Nat Nanotechnol. 2024; 19(6):716-717.

PMID: 38548909 DOI: 10.1038/s41565-024-01631-3.

References
1.
Martinez-Reyes I, Chandel N . Cancer metabolism: looking forward. Nat Rev Cancer. 2021; 21(10):669-680. DOI: 10.1038/s41568-021-00378-6. View

2.
Schiliro C, Firestein B . Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells. 2021; 10(5). PMC: 8146072. DOI: 10.3390/cells10051056. View

3.
Koundouros N, Poulogiannis G . Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2019; 122(1):4-22. PMC: 6964678. DOI: 10.1038/s41416-019-0650-z. View

4.
Eniafe J, Jiang S . The functional roles of TCA cycle metabolites in cancer. Oncogene. 2021; 40(19):3351-3363. DOI: 10.1038/s41388-020-01639-8. View

5.
Nakhle J, Rodriguez A, Vignais M . Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer. Int J Mol Sci. 2020; 21(12). PMC: 7352686. DOI: 10.3390/ijms21124405. View